Co-Treatment With Verapamil and Curcumin Attenuates the Behavioral Alterations Observed in Williams–Beuren Syndrome Mice by Regulation of MAPK Pathway and Microglia Overexpression
Williams–Beuren syndrome (WBS) is a rare neurodevelopmental disorder characterized by a distinctive cognitive phenotype for which there are currently no effective treatments. We investigated the progression of behavioral deficits present in WBS complete deletion (CD) mice, after chronic treatment wi...
Main Authors: | Paula Ortiz-Romero, Alejandro González-Simón, Gustavo Egea, Luis A. Pérez-Jurado, Victoria Campuzano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.670785/full |
Similar Items
-
Williams-Beuren Syndrome with Brain Dysplasia
by: J Gordon Millichap
Published: (2013-10-01) -
Prevalence of scoliosis in Williams-Beuren syndrome patients treated at a regional reference center
by: Marcelo Loquette Damasceno, et al.
Published: (2014-07-01) -
Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview
by: Marta Ferrari, et al.
Published: (2021-05-01) -
Síndrome de Williams-Beuren. Enfoque diagnóstico a través del fenotipo
by: María Angelina Lacruz-Rengel, et al.
Published: (2015-10-01) -
Williams–Beuren syndrome: a complete guide for oral healthcare
by: Patil Pavan Manohar, et al.
Published: (2021-01-01)